178 related articles for article (PubMed ID: 8903846)
1. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection.
Takao T; Hashimoto K; De Souza EB
Brain Behav Immun; 1995 Dec; 9(4):276-91. PubMed ID: 8903846
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptors in the brain-endocrine-immune axis. Modulation by stress and infection.
Takao T; Hashimoto K; De Souza EB
Ann N Y Acad Sci; 1995 Dec; 771():372-85. PubMed ID: 8597415
[TBL] [Abstract][Full Text] [Related]
3. Modulation of interleukin-1 receptors in the neuro-endocrine-immune axis.
Takao T; Hashimoto K; De Souza EB
Int J Dev Neurosci; 1995; 13(3-4):167-78. PubMed ID: 7572273
[TBL] [Abstract][Full Text] [Related]
4. Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress.
Pournajafi Nazarloo H; Takao T; Nanamiya W; Asaba K; De Souza EB; Hashimoto K
Brain Res; 2001 May; 902(1):119-26. PubMed ID: 11376601
[TBL] [Abstract][Full Text] [Related]
5. Age-related reciprocal modulation of interleukin-1beta and interleukin-1 receptors in the mouse brain-endocrine-immune axis.
Takao T; Nagano I; Tojo C; Takemura T; Makino S; Hashimoto K; De Souza EB
Neuroimmunomodulation; 1996; 3(4):205-12. PubMed ID: 9094441
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-dependent modulation of interleukin-1 receptors in the mouse AtT-20 pituitary tumor cell line.
Takao T; Dieterich KD; Tracey DE; De Souza EB
Brain Res; 1994 Sep; 656(1):177-81. PubMed ID: 7804834
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal modulation of interleukin-1 beta (IL-1 beta) and IL-1 receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis.
Takao T; Culp SG; De Souza EB
Endocrinology; 1993 Apr; 132(4):1497-504. PubMed ID: 8462448
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor treatment upregulates interleukin-1 receptors in the mouse pituitary: reversal by dexamethasone.
Takao T; Tojo C; Nishioka T; Hashimoto K; De Souza EB
Brain Res; 1995 Aug; 688(1-2):219-22. PubMed ID: 8542313
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal modulation of corticotropin-releasing factor and interleukin-1 receptors following ether-laparotomy stress in the mouse.
Takao T; Tojo C; Nishioka T; Kurokawa H; Takemura T; Hashimoto K; De Souza EB
Brain Res; 1994 Oct; 660(1):170-4. PubMed ID: 7827996
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis.
De Souza EB; Webster EL; Grigoriadis DE; Tracey DE
Psychopharmacol Bull; 1989; 25(3):299-305. PubMed ID: 2560554
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor.
Webster EL; Tracey DE; De Souza EB
Endocrinology; 1991 Nov; 129(5):2796-8. PubMed ID: 1834455
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor and interleukin-1 receptors in the brain-endocrine-immune axis. Role in stress response and infection.
De Souza EB
Ann N Y Acad Sci; 1993 Oct; 697():9-27. PubMed ID: 8257026
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of one and repeated endotoxin treatment on pituitary- adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha.
Nagano I; Takao T; Nanamiya W; Takemura T; Nishiyama M; Asaba K; Makino S; De Souza EB; Hashimoto K
Neuroimmunomodulation; 1999; 6(4):284-92. PubMed ID: 10393514
[TBL] [Abstract][Full Text] [Related]
14. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells.
Kageyama K; Suda T
Neuroimmunomodulation; 2001; 9(6):326-32. PubMed ID: 12045360
[TBL] [Abstract][Full Text] [Related]
15. Type I interleukin-1 receptors in the mouse brain-endocrine-immune axis labelled with [125I]recombinant human interleukin-1 receptor antagonist.
Takao T; Culp SG; Newton RC; De Souza EB
J Neuroimmunol; 1992 Nov; 41(1):51-60. PubMed ID: 1460092
[TBL] [Abstract][Full Text] [Related]
16. Modulation of interleukin-1 receptors followed by endotoxin lipopolysaccharide treatment in the mouse AtT-20 pituitary tumor cell line.
Kumagai C; Takao T; Matsumoto R; Asaba K; Hashimoto K
Neuroimmunomodulation; 2002-2003; 10(5):310-6. PubMed ID: 12759568
[TBL] [Abstract][Full Text] [Related]
17. Modulation of type I IL-1 receptor and IL-1 beta mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse.
Pournajafi Nazarloo H; Takao T; Taguchi T; Ito H; Hashimoto K
J Neuroimmunol; 2003 Jul; 140(1-2):102-8. PubMed ID: 12864977
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
Aubry JM; Turnbull AV; Pozzoli G; Rivier C; Vale W
Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723
[TBL] [Abstract][Full Text] [Related]
19. Role of brain, pituitary and spleen corticotropin-releasing factor receptors in the stress response.
De Souza EB; Grigoriadis DE; Webster EL
Methods Achiev Exp Pathol; 1991; 14():23-44. PubMed ID: 1658548
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
